Cargando…

An Assessment of Histological Margins and Recurrence of Melanoma In Situ

BACKGROUND: Melanoma in situ (MIS) accounts for up to 27% of all melanomas. MIS has no metastatic potential and the aim should be to excise the lesion completely with a clear histological margin, although margin clearance remains undefined. We aimed to assess the relation of histological excision ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Joyce, Kenneth M., Joyce, Cormac W., Jones, Deirdre M., Donnellan, Paul, Hussey, Alan J., Regan, Padraic J., Kelly, Jack L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350307/
https://www.ncbi.nlm.nih.gov/pubmed/25750840
http://dx.doi.org/10.1097/GOX.0000000000000272
_version_ 1782360170618159104
author Joyce, Kenneth M.
Joyce, Cormac W.
Jones, Deirdre M.
Donnellan, Paul
Hussey, Alan J.
Regan, Padraic J.
Kelly, Jack L.
author_facet Joyce, Kenneth M.
Joyce, Cormac W.
Jones, Deirdre M.
Donnellan, Paul
Hussey, Alan J.
Regan, Padraic J.
Kelly, Jack L.
author_sort Joyce, Kenneth M.
collection PubMed
description BACKGROUND: Melanoma in situ (MIS) accounts for up to 27% of all melanomas. MIS has no metastatic potential and the aim should be to excise the lesion completely with a clear histological margin, although margin clearance remains undefined. We aimed to assess the relation of histological excision margins of MIS to recurrence and progression to invasive disease. METHODS: We analyzed all patients with MIS excised by wide local excision or staged excision in our institution over a 5-year period from December 2008 to January 2014 using a prospectively maintained database. Clinicopathologic details included patient demographics, anatomical site of lesion, melanoma subtype, histological excision margin, and recurrence. RESULTS: A total of 410 patients had MIS excised during this time, the majority of which were lentigo maligna subtype (79%). The average histological excision margin was 3.7 mm. The rate of recurrence was 2.2% (9/410), with a median follow-up of 23 months. Lentigo maligna had a similar rate of recurrence to non-lentigo MIS (2.3% vs 1.2%) (P = 0.69). The mean excision margin of those that recurred was 1.9 mm compared with an average of 3.8 mm in those that did not. The rate of recurrence of MIS with histological excision margin ≤3.00 mm was 3.8% compared with 0.5% in those with a histological margin >3.00 mm (P = 0.03). One case of MIS recurred as invasive disease. CONCLUSION: At institutions using wide local excision or staged excision for MIS, a histological margin of >3.0 mm is required to achieve a low recurrence rate.
format Online
Article
Text
id pubmed-4350307
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-43503072015-03-06 An Assessment of Histological Margins and Recurrence of Melanoma In Situ Joyce, Kenneth M. Joyce, Cormac W. Jones, Deirdre M. Donnellan, Paul Hussey, Alan J. Regan, Padraic J. Kelly, Jack L. Plast Reconstr Surg Glob Open Original Article BACKGROUND: Melanoma in situ (MIS) accounts for up to 27% of all melanomas. MIS has no metastatic potential and the aim should be to excise the lesion completely with a clear histological margin, although margin clearance remains undefined. We aimed to assess the relation of histological excision margins of MIS to recurrence and progression to invasive disease. METHODS: We analyzed all patients with MIS excised by wide local excision or staged excision in our institution over a 5-year period from December 2008 to January 2014 using a prospectively maintained database. Clinicopathologic details included patient demographics, anatomical site of lesion, melanoma subtype, histological excision margin, and recurrence. RESULTS: A total of 410 patients had MIS excised during this time, the majority of which were lentigo maligna subtype (79%). The average histological excision margin was 3.7 mm. The rate of recurrence was 2.2% (9/410), with a median follow-up of 23 months. Lentigo maligna had a similar rate of recurrence to non-lentigo MIS (2.3% vs 1.2%) (P = 0.69). The mean excision margin of those that recurred was 1.9 mm compared with an average of 3.8 mm in those that did not. The rate of recurrence of MIS with histological excision margin ≤3.00 mm was 3.8% compared with 0.5% in those with a histological margin >3.00 mm (P = 0.03). One case of MIS recurred as invasive disease. CONCLUSION: At institutions using wide local excision or staged excision for MIS, a histological margin of >3.0 mm is required to achieve a low recurrence rate. Wolters Kluwer Health 2015-03-06 /pmc/articles/PMC4350307/ /pubmed/25750840 http://dx.doi.org/10.1097/GOX.0000000000000272 Text en Copyright © 2015 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Original Article
Joyce, Kenneth M.
Joyce, Cormac W.
Jones, Deirdre M.
Donnellan, Paul
Hussey, Alan J.
Regan, Padraic J.
Kelly, Jack L.
An Assessment of Histological Margins and Recurrence of Melanoma In Situ
title An Assessment of Histological Margins and Recurrence of Melanoma In Situ
title_full An Assessment of Histological Margins and Recurrence of Melanoma In Situ
title_fullStr An Assessment of Histological Margins and Recurrence of Melanoma In Situ
title_full_unstemmed An Assessment of Histological Margins and Recurrence of Melanoma In Situ
title_short An Assessment of Histological Margins and Recurrence of Melanoma In Situ
title_sort assessment of histological margins and recurrence of melanoma in situ
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350307/
https://www.ncbi.nlm.nih.gov/pubmed/25750840
http://dx.doi.org/10.1097/GOX.0000000000000272
work_keys_str_mv AT joycekennethm anassessmentofhistologicalmarginsandrecurrenceofmelanomainsitu
AT joycecormacw anassessmentofhistologicalmarginsandrecurrenceofmelanomainsitu
AT jonesdeirdrem anassessmentofhistologicalmarginsandrecurrenceofmelanomainsitu
AT donnellanpaul anassessmentofhistologicalmarginsandrecurrenceofmelanomainsitu
AT husseyalanj anassessmentofhistologicalmarginsandrecurrenceofmelanomainsitu
AT reganpadraicj anassessmentofhistologicalmarginsandrecurrenceofmelanomainsitu
AT kellyjackl anassessmentofhistologicalmarginsandrecurrenceofmelanomainsitu
AT joycekennethm assessmentofhistologicalmarginsandrecurrenceofmelanomainsitu
AT joycecormacw assessmentofhistologicalmarginsandrecurrenceofmelanomainsitu
AT jonesdeirdrem assessmentofhistologicalmarginsandrecurrenceofmelanomainsitu
AT donnellanpaul assessmentofhistologicalmarginsandrecurrenceofmelanomainsitu
AT husseyalanj assessmentofhistologicalmarginsandrecurrenceofmelanomainsitu
AT reganpadraicj assessmentofhistologicalmarginsandrecurrenceofmelanomainsitu
AT kellyjackl assessmentofhistologicalmarginsandrecurrenceofmelanomainsitu